phenylalanyl-leucyl-arginyl phenylalaninamide has been researched along with caffeine in 1 studies
Studies (phenylalanyl-leucyl-arginyl phenylalaninamide) | Trials (phenylalanyl-leucyl-arginyl phenylalaninamide) | Recent Studies (post-2010) (phenylalanyl-leucyl-arginyl phenylalaninamide) | Studies (caffeine) | Trials (caffeine) | Recent Studies (post-2010) (caffeine) |
---|---|---|---|---|---|
40 | 0 | 0 | 25,501 | 2,393 | 6,825 |
Protein | Taxonomy | phenylalanyl-leucyl-arginyl phenylalaninamide (IC50) | caffeine (IC50) |
---|---|---|---|
Acetylcholinesterase | Homo sapiens (human) | 7.25 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shinozaki, T; ter Keurs, HE; Wilkens, JL; Yazawa, T | 1 |
1 other study(ies) available for phenylalanyl-leucyl-arginyl phenylalaninamide and caffeine
Article | Year |
---|---|
Sites and modes of action of proctolin and the FLP F2 on lobster cardiac muscle.
Topics: Animals; Cadmium; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Fluorescence; Membrane Potentials; Microelectrodes; Myocardial Contraction; Myocardium; Nephropidae; Neuropeptides; Nifedipine; Oligopeptides; Ryanodine; Sarcoplasmic Reticulum; Verapamil | 2005 |